Learn about the ISN’s work in advocacy below.
Baxter and ISN collaborate to address growing prevalence of kidney disease
ISN has announced a partnership to advance chronic kidney disease (CKD) awareness and help improve access to therapy, particularly in low- and middle-income countries (LMIC) – commonly referenced as emerging countries – where the disease prevalence is growing the fastest. The collaboration will support greater disease and therapy research and education, as well as work...
Supporting nephrology in Asia Pacific
ISN and the Asian Pacific Society of Nephrology (APSN) have joined forces, building on their common expertise to bridge the gaps that exist in providing valuable care for kidney disease patients across Asia Pacific. Among many sponsorship activities, APSN co-fund several programs every year to increase capacity in East Asia, South Asia, Southeast Asia, and...
Apply or make a nomination for the DICG Council
We are now calling for expressions of interest or nominations for two positions on the Declaration of Istanbul Custodian Group (DICG) Council. ISN ExCom and Council have decided that henceforward expressions of interest and nominations will be called for and decided on, using transparent and uniform processes, for leadership positions within ISN. Deadline is...
ISN joins NCDA
ISN is pleased to have become a full member of the NCD Alliance (NCDA) to accelerate political commitment and action on non-communicable diseases (NCDs) worldwide, including kidney disease. Prof. David Harris, ISN President said: ‘We are delighted to work with colleagues from other disease communities to keep the pressure on United Nation Member States and...